TheraMyc Ltd
Pharmaceuticals - Leicester, England, United Kingdom
TheraMyc Ltd Employees
TheraMyc Ltd Details
TheraMyc is an early clinical-stage biotech targeting MYC addicted cancers with a novel membrane penetrating synthetic peptide inhibitor. The Myc family of proto-oncogenes make proteins involved in many cell functions, including cell growth, cell maturation and cell death. Dysregulation of Myc has been found in the majority of cancers, both solid tumours and haematological malignancies. Direct targeting of the Myc family has eluded scientists in the 40 years since their discovery, due to their complex and intrinsically disordered nature. TheraMyc is developing the first stapled peptide inhibitor of MYC, capitalising on a platform of small, stable, cell-penetrating peptides that have the ability to bind and inhibit the function of dysregulated intrinsically disordered proteins (IDPs).Our Senior Management Team has extensive expertise in global and regional drug development, with a combined experience of over 100 years.World-leading physicians and scientists working in the field of Myc-related cancers have also been engaged as part of our Scientific Advisory Board, and will provide scientific and medical advice to a comprehensive clinical program in patients with a range of solid and haematological malignancies.We are proud and excited to be part of an endeavour that has such transformative potential in cancer therapy.
TheraMyc Ltd Technologies
Hosting
Microsoft Azure Hosting